Moderna TodayMRNAModerna$25.80 -2.19 (-7.82%) 52-Week Range$23.15▼$170.47Price Target$53.95Add to WatchlistModerna Inc. NASDAQ: MRNA is down 35% in 2025, making it one of the worst-performing stocks among medical stocks and the broader market. Not surprisingly, the stock is down over 80% in the last 12 months. What may surprise investors is that the Moderna stock is down approximately 60% over the last five years. That means the stock has given back all the gains it made when the company’s COVID-19 vaccine ...